NGS Adoption For Viral Safety: From Experimental Tool To Regulatory-Endorsed Standard

Two decades after revolutionizing genomics, Next Generation Sequencing (NGS) is reaching a critical inflection point in biopharmaceutical development. Transitioning from an exploratory research tool to a validated, regulatory-endorsed standard, NGS is now reshaping viral safety testing for biological medicinal products.

Donna McMutrie, Head of Strategy for Large Molecules, and Arnoud Boot, Senior Product Developer, trace this evolution, examining the scientific and operational hurdles that historically constrained NGS and the breakthroughs that are driving its widespread adoption. Get a comprehensive look at the future of viral safety for professionals in strategy, quality, regulatory affairs, and technical development.